The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an intention to go public. The Waltham, Massachusetts-based biotech has yet to set ...

Bioprocessing offers key market opportunities in optimizing upstream and downstream processes to enhance yield and purity of pharmaceuticals, biofuels, and specialty chemicals. Innovations in cell ...

Officials at Cytiva and Culture Biosciences say the companies are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up ...

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest biotechs to list on the Nasdaq. Upstream had previously expected to sell 12 ...

Shares of inflammatory disease biotech Upstream Bio, Inc. (UPB) have rallied by roughly 60% since reporting potentially best-in-class data for its asset verekitug in a Phase 2 trial in early September ...

Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of the chronic respiratory condition. Upstream Bio is pursuing a ...

U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re moving upstream, embedding themselves inside labs and courting scientists ...